In Collaboration with JHM Biopharma – Your Trusted Source for Injectable-Grade Collagen & Toxins
About JHM Biopharma
JHM Biopharma is a leading biotech innovator based in China, specializing in the development and manufacturing of advanced injectable-grade ingredients for aesthetic medicine. With a strong R&D pipeline, regulatory expertise, and clinical capabilities, JHM focuses on two flagship products:
- Recombinant Collagen
- Recombinant Botulinum Toxin
Both products serve as core raw materials for aesthetic end-products and are developed to meet injection-grade quality and safety standards, far exceeding conventional cosmetic-use materials such as DNA-based raw materials.
Regulatory Readiness in China
JHM’s injectable products are currently undergoing clinical trials in China and are expected to complete regulatory submission in early 2026, paving the way for official market approval.
This positions JHM as one of the few Chinese biotech firms prepared to supply fully compliant, injectable-grade ingredients for the fast-growing medical aesthetics industry.
Innovating Together in Aesthetic Biotech
Recognizing the unique regulatory landscape for injectable raw materials across different countries, JHM Biopharma and Yakulink are pleased to offer two flexible collaboration models tailored for our valued partners in Japan. Whether you’re exploring the Chinese market or developing products for local approval, we’re here to support you every step of the way.
1. China-Oriented Strategy
If your company manufactures aesthetic end-products in Japan for export and sale in the Chinese market, JHM’s approved raw materials can be directly integrated into your production.
→ The regulatory process in China is relatively streamlined.
→ Yakulink will coordinate communication and logistics.
2. Japan-Oriented Strategy
If your goal is to develop or register an end-product containing JHM’s raw materials for the Japanese market, JHM is ready to support the process.
→ Technical collaboration for formulation and registration.
→ Yakulink acts as your local liaison for business coordination.
Yakulink – Your Gateway to Strategic Partnership
As the exclusive liaison for JHM Biopharma in Japan, Yakulink facilitates communication, documentation, and strategic alignment. While we handle the commercial interface, JHM provides full technical support, including product dossiers, testing data, and regulatory consultation.
If your company is exploring innovative injectable ingredients with proven clinical backing and regulatory foresight, we invite you to discuss further collaboration.